| RS863223855 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS863223856 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Colorectal cancer |
| RS863223857 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Loeys-Dietz syndrome |
| RS863223859 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863223860 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 8, Combined oxidative phosphorylation defect type 8 |
| RS863223862 |
AARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863223871 |
ACAD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863223881 |
ACO2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863223884 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS863223887 |
COQ8A
|
Health Risk |
Likely pathogenic |
— |
| RS863223895 |
AGK
|
Health Risk |
Pathogenic |
Sengers syndrome, Sengers syndrome |
| RS863223897 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Combined oxidative phosphorylation deficiency |
| RS863223898 |
AIFM1
|
Health Risk |
Likely pathogenic |
— |
| RS863223900 |
ALAS2
|
Health Risk |
Pathogenic |
X-linked sideroblastic anemia 1, Pancreatic adenocarcinoma |
| RS863223901 |
ALAS2
|
Health Risk |
Pathogenic |
— |
| RS863223902 |
ALAS2
|
Health Risk |
Likely pathogenic |
— |
| RS863223903 |
ALAS2
|
Health Risk |
Likely pathogenic |
— |
| RS863223904 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863223906 |
ALAS2
|
Health Risk |
Pathogenic |
— |
| RS863223910 |
ATPAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863223911 |
AUH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS863223913 |
AUH
|
Health Risk |
Likely pathogenic |
— |
| RS863223915 |
BCS1L
|
Health Risk |
Pathogenic |
— |
| RS863223916 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863223919 |
TWNK
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile onset spinocerebellar ataxia, Infantile onset spinocerebellar ataxia |
| RS863223920 |
TWNK
|
Health Risk |
Pathogenic |
— |
| RS863223921 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile onset spinocerebellar ataxia, Autosomal recessive cerebellar ataxia |
| RS863223925 |
TWNK
|
Health Risk |
Pathogenic |
— |
| RS863223926 |
MTRFR
|
Health Risk |
Pathogenic |
Spastic paraplegia, Combined oxidative phosphorylation defect type 7 |
| RS863223931 |
NDUFAF6
|
Health Risk |
Likely pathogenic |
— |
| RS863223932 |
NDUFAF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 17 |
| RS863223936 |
COQ2
|
Health Risk |
Pathogenic |
— |
| RS863223948 |
DGUOK
|
Health Risk |
Pathogenic |
— |
| RS863223949 |
DGUOK
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS863223953 |
DNM1L
|
Health Risk |
Pathogenic |
Encephalopathy, lethal |
| RS863223954 |
ETHE1
|
Health Risk |
Likely pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS863223955 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS863223956 |
ETHE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS863223962 |
FASTKD2
|
Health Risk |
Likely pathogenic |
— |
| RS863223965 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863223966 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863223967 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223968 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863223969 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863223972 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223973 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223974 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223977 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223978 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Fumarase deficiency, Hereditary leiomyomatosis and renal cell cancer |
| RS863223979 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223980 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863223981 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223982 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223983 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223984 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863223985 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863223987 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS863223988 |
FH
|
Health Risk |
Pathogenic |
— |
| RS863223989 |
FH
|
Health Risk |
Pathogenic |
— |
| RS863223990 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863223991 |
FH
|
Health Risk |
Pathogenic |
— |
| RS863223992 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS863223993 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863223994 |
FH
|
Health Risk |
Pathogenic |
— |
| RS863223995 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863223997 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS863223998 |
FH
|
Health Risk |
Pathogenic |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS863224000 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224001 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224002 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224003 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863224004 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224006 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224007 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Fumarase deficiency |
| RS863224008 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS863224009 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224010 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS863224011 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS863224012 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS863224013 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224015 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224016 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS863224017 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS863224018 |
FOXRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS863224019 |
FOXRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224020 |
FOXRED1
|
Health Risk |
Likely pathogenic |
— |
| RS863224022 |
G6PC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS863224023 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS863224028 |
GFER
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial disease, Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome |
| RS863224030 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS863224032 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS863224033 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS863224035 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224039 |
GYS2
|
Health Risk |
Likely pathogenic |
— |
| RS863224040 |
HARS2
|
Health Risk |
Likely pathogenic |
— |
| RS863224042 |
HSPD1
|
Health Risk |
Likely pathogenic |
— |
| RS863224045 |
LARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS863224047 |
LARS1
|
Health Risk |
Pathogenic |
— |
| RS863224048 |
LARS1
|
Health Risk |
Pathogenic |
— |
| RS863224052 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |